The pharmaceutical sector in India presents a intricate landscape, increasingly marked by concerns surrounding monopoly . While the nation boasts a vibrant generic market, a few significant companies maintain a considerable stake of the business , sparking questions about rivalry and consumer access to inexpensive drugs . This scenario is fueled by

The pharmaceutical landscape in the nation is increasingly characterized by a tendency toward market concentration, with a handful of prominent companies wielding significant control. These business giants, often bolstered by established distribution networks and robust brand recognition, present a complex picture for competition and accessible hea

The Indian pharmaceutical industry, known for its affordable and accessible medicines, faces increasing concerns about monopolies. A few dominant companies control a significant share of the market, potentially restricting competition and driving up prices for consumers. This situation raises worries about the long-term impact on patient access to